The more NEU de-risks approval of trofintide, higher the $$ Big Pharma will be willing to fork out, so from NEU’s perspective a deal done after Phase 3 of Retts and NDA application of trof probably suits best to get max $$. (Same scenario was played out at ACR, so RT is in tune with this strategy and I can’t see a reason not to continue the same winning formula).
Having said that, there is nothing stopping a Big pharma to come with an outstanding $$ offer prior which NEU might be tempted to take (but I feel this is less likely prior to results from paediatric trial)
Gut feel is a min of $1 post and a max of $4 post deal
The more NEU de-risks approval of trofintide, higher the $$ Big...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |